ClinicalTrials.gg
CompletedNCT01891435Updated Jul 3, 2013

The Antipyretic Efficacy of Oral and Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever.

An interventional study of Oral paracetamol and Intravenous paracetamol in Fever and Reduction in Temperature, sponsored by Hamad Medical Corporation. Completed at 1 site in Qatar. Open to participants aged 14 Years to 75 Years. Per ClinicalTrials.gov, last updated 2013-07-03.

Sponsored by Hamad Medical Corporation · Not applicable, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
434
Allocation
Randomized
Ages
14 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 31 studies testing acetaminophen in Fever — 1 open to participants now, 1 under way, none of them phase 3. Acetaminophen · Fever.

Enrollment
Largest of 31
434 · median 100
Started
2010
with 3 others
No phase
6 of 31
1 open now
Registered
20th of 31
by date
Lead sponsor
1 of 31
Hamad Medical Corporation

Among the 31 studies testing acetaminophen in Fever, this one has the largest enrollment, is one of 4 that started in 2010, is one of 6 with no phase, and was the 20th registered.

Fever

438 studies on the registry are indexed under Fever; 55 are open to participants now.

Browse Fever studies →

Open to participants now

1 of the 31 studies testing acetaminophen in Fever is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

About acetaminophen

Acetaminophen: first FDA approval 1968 (NEOPAP). What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 38 Fever studies recruiting now, 18 (47%) set no upper age limit and 14 (37%) stop at 75 or younger; 22 take children under 18; 11 take healthy volunteers.

This study: 14 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 31 studies testing acetaminophen in Fever, or all of them as a file.
02

Study summary

A randomized clinical trial to check the antipyretic efficacy of oral and intravenous paracetamol and intramuscular diclofenac sodium in patients presenting with fever to emergency department.

03

Conditions studied

  • Fever
  • Reduction in Temperature

Keywords

  • antipyretics
  • oral paracetamol
  • intravenous paracetamol
  • intramuscular diclofenac
  • emergency department
04

Who can participate

Ages eligible
14 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults between the age of 14-75 years with an oral temperature of more than 38.5 C

Exclusion criteria

Exclusion Criteria:

  • History of allergy to any of the drugs in the study
  • Had taken antipyretics within 8 hours
  • Renal, hepatic or haematological disorders
  • bronchial asthma, peptic ulcer disease, vomiting
  • Pregnant or lactating women
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
434 participants (actual)

Study arms

  • Active comparator
    oral paracetamol

    patients in this arm will receive 1000mg of oral paracetamol

    Drug: Oral paracetamol

  • Active comparator
    Intravenous paracetamol

    patients in this arm will receive 1000 mg of intravenous paracetamol

    Drug: Intravenous paracetamol

  • Active comparator
    Intramuscular Diclofenac

    patients in this arm will receive 75 mg of intramuscular diclofenac sodium

    Drug: Intramuscular diclofenac

Interventions

06

What researchers measure

Primary outcomes

  1. Reduction in temperature in every thirty minutes till 120 minutes after receiving antipyretics

    Once the patients fulfill the inclusion criteria, they are randomly assigned to receive one of the three medications in the study ( oral paracetamol, intravenous paracetamol or intramuscular diclofenac). Baseline temperature is recorded using a standard thermometer. Then reduction in temperature is recorded every 30 minutes for 2 hours.

    Time frame: Reduction in temperature is checked every 30 minutes for a maximum of 120 minutes

07

Study locations

1 site
  • Hamad medical corporation
    Doha, 3050, Qatar
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2010, a primary completion of Dec 2011 and a completion of Apr 2013. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 21, 2013
First posted
Jul 3, 2013
Start
Jan 2010
Primary completionActual
Dec 2011
CompletionActual
Apr 2013
Last update
Jul 3, 2013
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 3, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01891435
Responsible party
Firjeeth C Paramba (Specialist, Emergency Department, Hamad Medical Corporation) — Principal investigator
First posted
Jul 3, 2013
Start date
Jan 2010
Primary completion
Dec 2011
Completion
Apr 2013
Last update
Jul 3, 2013

Study contacts

osama H Mohammed
principal investigator · Hamad Medical Corporation
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Acetaminophen · Diclofenac

Start the discussion